Alterations to the Gastrointestinal Microbiome Associated with Methamphetamine Use among Young Men who have Sex with Men
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Curated date: 2021/01/10
Curator: WikiWorks
Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Joan Chuks, Fiddyhamma
Subjects
- Location of subjects
- United States of America
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Rectum
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Methamphetamine dependence Amphetamine-Related Disorders,metamphetamine addiction,metamphetamine dependence,Methamphetamine dependence,methamphetamine dependence
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- HIV-positive non-MA users
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- HIV-positive MA users
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- HIV-positive Men who have sex with men (MSM) who self-reported methamphetamine (MA) use in the past six months
- Group 0 sample size Number of subjects in the control (unexposed) group
- 81
- Group 1 sample size Number of subjects in the case (exposed) group
- 101
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Statistical test
- Negative Binomial Regression
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.1
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age, alcohol drinking, ethnic group, smoking behavior, antibiotic, cannabis use, HIV/AIDS pre-exposure prophylaxis, receptive anal intercourse frequency, antiretroviral therapy, homelessness, sexually transmitted infection, substance use, number of sex partners
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
- Richness Number of species
- unchanged
Signature 1
Source: Text, Supplementary Table S2, Figure 3
Description: Differential abundance of bacterial genera between HIV+ methamphetamine users and non-users
Abundance in Group 1: increased abundance in HIV-positive MA users
NCBI | Quality Control | Links |
---|---|---|
Actinomyces | ||
Mannheimia | ||
Negativicoccus | ||
Streptobacillus |
Revision editor(s): Claregrieve1, WikiWorks
Experiment 2
Curated date: 2021/01/10
Curator: WikiWorks
Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Joan Chuks, Fiddyhamma
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Methamphetamine dependence Amphetamine-Related Disorders,metamphetamine addiction,metamphetamine dependence,Methamphetamine dependence,methamphetamine dependence
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- non-users
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Methamphetamine users
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- MSM who self-reported methamphetamine (MA) use in the past six months
- Group 0 sample size Number of subjects in the control (unexposed) group
- 225
- Group 1 sample size Number of subjects in the case (exposed) group
- 156
Lab analysis
Statistical Analysis
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age, alcohol drinking, ethnic group, smoking behavior, antibiotic, cannabis use, HIV/AIDS pre-exposure prophylaxis, receptive anal intercourse frequency, homelessness, number of sex partners, sexually transmitted infection, substance use, antiretroviral therapy
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
- Richness Number of species
- unchanged
Signature 1
Source: Text, Supplementary Table S2
Description: Differential abundance of bacterial genera between MA users and non-users
Abundance in Group 1: increased abundance in Methamphetamine users
Revision editor(s): WikiWorks
Signature 2
Source: Text, Supplementary Table S2
Description: Differential abundance of bacterial genera between MA users and non-users
Abundance in Group 1: decreased abundance in Methamphetamine users
NCBI | Quality Control | Links |
---|---|---|
Butyricicoccus | ||
Faecalibacterium | ||
Alloprevotella |
Revision editor(s): WikiWorks
Experiment 3
Curated date: 2021/01/10
Curator: WikiWorks
Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Joan Chuks, Fiddyhamma
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- MSM who did not test positive on MA urine drug screening
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- MSM who tested positive on MA urine drug screening
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- MSM who tested positive for methamphetamine (MA) use in a urine drug screening
- Group 0 sample size Number of subjects in the control (unexposed) group
- 329
- Group 1 sample size Number of subjects in the case (exposed) group
- 52
Lab analysis
Statistical Analysis
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age, alcohol drinking, ethnic group, smoking behavior, antibiotic, cannabis use, HIV/AIDS pre-exposure prophylaxis, receptive anal intercourse frequency, homelessness, antiretroviral therapy, substance use, sexually transmitted infection, number of sex partners
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
- Richness Number of species
- unchanged
Signature 1
Source: Supplementary Figure S6, Results within text (Page 5, under subheading "Dose-response analysis of bacterial counts on increasing frequency of MA use"
Description: Sensitivity analysis using urine toxicology screening to define MA use
Abundance in Group 1: increased abundance in MSM who tested positive on MA urine drug screening
NCBI | Quality Control | Links |
---|---|---|
Anaerococcus | ||
Corynebacterium | ||
Dietzia | ||
Eubacterium | ||
Finegoldia | ||
Fusobacterium | ||
Mogibacterium | ||
Murdochiella | ||
Peptoniphilus | ||
Peptostreptococcus | ||
Porphyromonas |
Revision editor(s): WikiWorks, ChiomaBlessing
Signature 2
Source: Text, Supplementary Figure 4-6
Description: Sensitivity analysis using urine toxicology screening to define MA use
Abundance in Group 1: decreased abundance in MSM who tested positive on MA urine drug screening
NCBI | Quality Control | Links |
---|---|---|
Faecalibacterium | ||
Clostridium | ||
Lactobacillus | ||
Oligosphaera | ||
Succinivibrio |
Revision editor(s): WikiWorks
Experiment 4
Curated date: 2021/01/10
Curator: WikiWorks
Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Joan Chuks, Fiddyhamma
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- HIV-positive men who have sex with men who did not test positive in a methamphetamine drug screening
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- HIV-positive men who have sex with men who tested positive in a methamphetamine drug screening
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- HIV-positive Men who have sex with men (MSM) who tested positive in a methamphetamine (MA) drug screening
- Group 0 sample size Number of subjects in the control (unexposed) group
- 81
- Group 1 sample size Number of subjects in the case (exposed) group
- 21
Lab analysis
Statistical Analysis
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age, alcohol drinking, ethnic group, smoking behavior, antibiotic, cannabis use, HIV/AIDS pre-exposure prophylaxis, receptive anal intercourse frequency, antiretroviral therapy, homelessness, number of sex partners, sexually transmitted infection, substance use
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
- Richness Number of species
- unchanged
Signature 1
Source: Text, Supplementary Figure 4-6
Description: Differential microbial abundance between MA+ and MA- stratified by HIV (Using urine toxicology screening to define MA use in HIV-positive MSM)
Abundance in Group 1: increased abundance in HIV-positive men who have sex with men who tested positive in a methamphetamine drug screening
NCBI | Quality Control | Links |
---|---|---|
Streptobacillus |
Revision editor(s): Claregrieve1, WikiWorks
Signature 2
Source: Text, Supplementary Figure 4-6
Description: Differential microbial abundance between MA+ and MA- in HIv+ patients (Using urine toxicology screening to define MA use in HIV-positive MSM)
Abundance in Group 1: decreased abundance in HIV-positive men who have sex with men who tested positive in a methamphetamine drug screening
NCBI | Quality Control | Links |
---|---|---|
Oxalobacter |
Revision editor(s): Claregrieve1, WikiWorks
Experiment 5
Curated date: 2021/01/10
Curator: WikiWorks
Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Joan Chuks, Fiddyhamma
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- HIV-negative MSM who did not test positive in a MA drug screening
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- HIV-negative MSM who tested positive in a MA drug screening
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- HIV-negative Men who have sex with men (MSM) who tested positive in a methamphetamine (MA) drug screening
- Group 0 sample size Number of subjects in the control (unexposed) group
- 248
- Group 1 sample size Number of subjects in the case (exposed) group
- 31
Lab analysis
Statistical Analysis
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age, alcohol drinking, ethnic group, smoking behavior, antibiotic, cannabis use, HIV/AIDS pre-exposure prophylaxis, receptive anal intercourse frequency, homelessness, number of sex partners, sexually transmitted infection, antiretroviral therapy, substance use
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
- Richness Number of species
- unchanged
Signature 1
Curated date: 2021/01/10
Curator: Michael Lutete
Revision editor(s): Claregrieve1, WikiWorks, ChiomaBlessing
Source: Supplementary Figure S6
Description: Differential microbial abundance between MA+ and MA- in HIV- men
Abundance in Group 1: increased abundance in HIV-negative MSM who tested positive in a MA drug screening
NCBI | Quality Control | Links |
---|---|---|
Clostridium |
Revision editor(s): Claregrieve1, WikiWorks, ChiomaBlessing
Signature 2
Curated date: 2021/01/10
Curator: Michael Lutete
Revision editor(s): Claregrieve1, WikiWorks, ChiomaBlessing
Source: Supplementary Figure S6
Description: Differential microbial abundance between MA+ and MA- in HIV- men
Abundance in Group 1: decreased abundance in HIV-negative MSM who tested positive in a MA drug screening
NCBI | Quality Control | Links |
---|---|---|
Barnesiella | ||
Granulicatella | ||
Sneathia | ||
Streptobacillus | ||
Subdoligranulum |
Revision editor(s): Claregrieve1, WikiWorks, ChiomaBlessing